Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of GYNECARE INTERCEED™ Absorbable Adhesion Barrier in Preventing the Abdominal Incision Adhesions

NCT03462563 is registered in ClinicalTrials.gov with Ethicon, Inc. as lead sponsor.

NCT NCT03462563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03462563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of GYNECARE INTERCEED™ Absorbable Adhesion Barrier in Preventing the Abdominal Incision Adhesions
Lead sponsor
Ethicon, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
April 16, 2018
Completion date
February 24, 2021
Enrollment
175 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

subjects scheduled to undergo laparoscopic radical resection of rectal carcinoma with preventive ileostomy